Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Vaxart Stock Tumbled in September

TheMotleyFool

0 0

Shares of the developmental-stage biotech Vaxart (NASDAQ: VXRT) sank by 11.5% last month, according to data provided by S&P Global Market Intelligence. The biotech's stock has been sliding hard over the past month and half for two related reasons:

Image source: Getty Images.

Vaxart's shares were once up by over 300% not so long ago. The biotech's stock has since given back the vast majority of these gains, especially over the past six weeks. Not all of these issues have been Vaxart's fault, however.

Source Fool.com

Like: 0

VXRT

Share